| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 03/16/2011 | EP2294058A1 2-(benzylsulfonyl)-oxazole derivatives, chiral 2- (benzylsulfinyl) -oxazole derivatives and 2-(benzylsulfanyl)-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/15/2011 | US7906653 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/15/2011 | CA2499721C Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists |
| 03/10/2011 | WO2011026781A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/10/2011 | US20110060011 Oxazole compounds compositions and methods of use |
| 03/10/2011 | CA2772975A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/09/2011 | EP2292628A2 Compounds for preparing immunological adjuvant |
| 03/09/2011 | EP2292595A1 Potassium channel modulators |
| 03/09/2011 | EP2292589A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/09/2011 | EP2292268A1 Pharmaceutical composition for use in treatment of diabetes |
| 03/09/2011 | EP2291351A1 Alpha-mercapto-amides |
| 03/09/2011 | EP2291349A2 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 03/09/2011 | EP1620434B1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 03/08/2011 | US7902238 2-aminooxazolines as TAAR1 ligands |
| 03/08/2011 | US7902175 Aminopropanol derivatives |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2338504C Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 03/03/2011 | WO2011025545A1 Sphingosine type 1 inhibitors and methods for making and using same |
| 03/03/2011 | WO2011024986A1 Organic electroluminescence device |
| 03/03/2011 | CA2793090A1 Sphingosine type 1 inhibitors and methods for making and using same |
| 03/02/2011 | EP2289556A2 Pharmaceutical composition for use in treatment of diabetes |
| 03/02/2011 | EP1578715B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/02/2011 | EP1417975B1 Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
| 03/02/2011 | CN101982468A Novel oxazolidinone derivatives and pharmaceutical compositions comprising the derivatives |
| 03/01/2011 | US7897815 Hexafluoroisopropanol derivatives |
| 02/24/2011 | WO2010096295A3 Oxazoline and/or oxazine compositions |
| 02/24/2011 | US20110046415 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof |
| 02/24/2011 | US20110046389 Intermediates for the preparation of (3r, 4s)-1-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)-3-hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone |
| 02/24/2011 | US20110046147 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases |
| 02/24/2011 | US20110046112 Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors |
| 02/23/2011 | EP1812388B1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 02/23/2011 | EP1656358B1 Stable polymorph of bifeprunox mesilate |
| 02/23/2011 | EP1383754B1 Process for making taxane derivatives |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | CN101981003A Amide compounds, compositions and uses thereof |
| 02/22/2011 | US7893274 Process for producing amino acid N-carboxyanhydride |
| 02/22/2011 | US7893258 Preparation of delmopinol |
| 02/22/2011 | US7892574 Topical administration of oxazolidinones for transdermal delivery |
| 02/22/2011 | CA2470575C Spiroazacyclic compounds as monoamine receptor modulators |
| 02/17/2011 | WO2011017907A1 Azetidinone compounds and medical use thereof |
| 02/17/2011 | US20110039888 Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones |
| 02/17/2011 | CA2770793A1 Azetidinone compounds and medical use thereof |
| 02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
| 02/16/2011 | CN101973953A Method for synthesizing chiral oxazoline |
| 02/16/2011 | CN101973952A Chiral oxazoline and synthetic method thereof |
| 02/16/2011 | CN101973951A Chiral D-oxazoline and application thereof |
| 02/16/2011 | CN101973829A Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger |
| 02/15/2011 | US7888513 Condensation reaction by metal catalyst |
| 02/15/2011 | US7888507 UV excitable fluorescent energy transfer dyes |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2444895C Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/10/2011 | US20110034518 Pharmaceutical composition |
| 02/10/2011 | US20110034516 Aminopyrazole derivatives |
| 02/10/2011 | US20110034450 Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof |
| 02/10/2011 | CA2769563A1 Novel compounds as modulators of glucocorticoid receptors |
| 02/09/2011 | EP2281819A1 Benzimidazolyl or benzoxazolyl derivatives |
| 02/09/2011 | EP2280927A1 Nitrated hydrocarbons, derivatives, and processes for their manufacture |
| 02/09/2011 | EP2280925A1 Process for the manufacture of nitropropanes |
| 02/09/2011 | EP2280707A1 Alpha2b and alpha2c agonists |
| 02/09/2011 | EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 02/09/2011 | CN101970420A Oxadiazole derivatives |
| 02/09/2011 | CN101970409A Uv-filter compounds |
| 02/03/2011 | WO2011014332A1 Selective alpha 2b/2c agonists |
| 02/03/2011 | WO2010131192A3 Novel oxazolidinone derivatives and their use as orexin receptor antagonists |
| 02/03/2011 | US20110028732 Nitrated hydrocarbons, derivatives, and processes for their manufacture |
| 02/03/2011 | US20110028731 Process for the manufacture of nitropropanes |
| 02/03/2011 | US20110028523 Selective Alpha 2B/2C Agonists |
| 02/03/2011 | US20110028463 Amide compounds |
| 02/03/2011 | US20110028367 Photo-labile pro-fragrance conjugates |
| 02/03/2011 | CA2769449A1 Selective alpha 2b/2c agonists |
| 02/02/2011 | EP2280006A1 Pharmaceutical composition for inhalation comprising an oxazole or thiazole m3 muscarinic receptor antagonist |
| 02/02/2011 | EP2278878A1 2-aryl glycinamide derivatives |
| 02/02/2011 | CN101504341B Preparation for eel muscle freeze-dried powder substrate standard substance containing furazolidone metabolite 3-amino-2-oxazolone(AOZ) |
| 02/01/2011 | US7879852 Melanocortin receptor agonists |
| 02/01/2011 | CA2484935C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 02/01/2011 | CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/27/2011 | WO2011011232A1 Dual-acting oxazole antihypertensive agents |
| 01/27/2011 | WO2011010715A1 Pr-set7 inhibitor |
| 01/27/2011 | US20110021762 Method of forming oseltamivir and derivatives thereof |
| 01/27/2011 | US20110021574 Anti-cancer compounds, synthesis thereof, and methods of using same |
| 01/27/2011 | US20110021573 Antagonists of prostaglandin d2 receptors |
| 01/27/2011 | US20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 |
| 01/27/2011 | US20110021534 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease |
| 01/27/2011 | US20110021528 Novel hydroxamates as therapeutic agents |
| 01/27/2011 | US20110021527 Dual-acting oxazole antihypertensive agents |
| 01/26/2011 | EP2277870A1 Substituted benzoxa(thia)zoles |
| 01/26/2011 | EP2277869A1 Cycloalkylamidbenzoxa(thia)zoles as fungicides |
| 01/26/2011 | EP2277868A1 Phenyloxy(thio)phenylamidbenzoxa(thia)zoles |
| 01/26/2011 | EP2277858A1 Amide compound |
| 01/26/2011 | EP2276753A1 Intermediates for the preparation of (3r, 4s) -1- (4-fluorophenyl) -3- [ (3s) -3- (4-fluorophenyl) -3-hydroxypropyl) ] -4- (4-hydroxyphenyl) -2-azetidinone |
| 01/26/2011 | EP2276345A1 Small-molecule inhibitors of the androgen receptor |
| 01/26/2011 | EP2114903B1 Bicyclic pyrimidinones and uses thereof |
| 01/25/2011 | CA2458528C C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as medicaments |
| 01/20/2011 | WO2011008560A1 Emissive aryl-heteroaryl compounds |
| 01/20/2011 | WO2011007819A1 Pharmaceutical product containing lactam or benzene sulfonamide compound |
| 01/19/2011 | EP2275398A1 Application of the iridium complex in asymmetric catalytic hydrogenation for unsaturated carboxylic acid |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP2274291A2 Reactive ionic liquids |
| 01/19/2011 | EP2274287A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |